Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories

被引:33
作者
Elomaa, Annika
Advani, Abdolreza
Donnelly, Declan
Antila, Mia
Mertsola, Jussi
He, Qiushui
Hallander, Hans
机构
[1] Natl Publ Hlth Inst, Pertussis Reference Lab, Turku 20520, Finland
[2] Swedish Inst Infect Dis Control, Dept Immunol & Vaccine Res, Solna, Sweden
[3] Turku Univ Hosp, Dept Pediat, FIN-20520 Turku, Finland
关键词
Bordetella pertussis; Bordetella virulence factors; pertussis vaccine;
D O I
10.1016/j.vaccine.2006.09.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pertussis is an infectious disease of the respiratory tract in humans caused by Bordetella pertussis. Despite extensive vaccinations, pertussis has remained endemic and re-emerged. In Finland, a whole-cell pertussis vaccine has been used since 1952 with high coverage. In Sweden, whole-cell vaccinations were introduced in 1953 but ceased in 1979, and pertussis vaccinations with acellular vaccines were introduced in 1996. Two epidemic peaks occurred in Sweden in 1999 and 2002 and in Finland in 1999 and 2003. We compared Finnish (N = 193) and Swedish (N = 455) B. pertussis isolates circulating in 1998-2003 together with vaccine strains used in these neighbouring countries with different vaccination histories. The isolates were analysed by serotyping, genotyping of pertussis toxin S I subunit and pertactin, and pulsed-field gel electrophoresis. The results suggest that the sequential epidemics were caused by clonal expansion of a certain B. pertussis strain possibly transmitted from Sweden to Finland. The roles of antigenic variation in immunity-driven evolution of B. pertussis in both countries are discussed. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:918 / 926
页数:9
相关论文
共 39 条
  • [11] Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs
    Hallander, HO
    Advani, A
    Donnelly, D
    Gustafsson, L
    Carlsson, RM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (06) : 2856 - 2865
  • [12] Hardwick TH, 2002, EMERG INFECT DIS, V8, P44
  • [13] Bordetella pertussis protein pertactin induces type-specific antibodies:: One possible explanation for the emergence of antigenic variants?
    He, QS
    Mäkinen, J
    Berbers, G
    Mooi, FR
    Viljanen, MK
    Arvilommi, H
    Mertsola, J
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (08) : 1200 - 1205
  • [14] Pertussis - Not just for kids
    Hewlett, EL
    Edwards, KM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (12) : 1215 - 1222
  • [15] Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan
    Kodama, A
    Kamachi, K
    Horiuchi, Y
    Konda, T
    Arakawa, Y
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (12) : 5453 - 5457
  • [16] Lashley Felissa R, 2004, Expert Rev Anti Infect Ther, V2, P299, DOI 10.1586/14787210.2.2.299
  • [17] Rapid typing of Bordetella pertussis pertussis toxin gene variants by LightCycler real-time PCR and fluorescence resonance energy transfer hybridization probe melting curve analysis
    Mäkinen, J
    Mertsola, J
    Viljanen, MK
    Arvilommi, H
    He, QS
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) : 2213 - 2216
  • [18] Rapid identification of Bordetella pertussis pertactin gene variants using LightCycler real-time polymerase chain reaction combined with melting curve analysis and gel electrophoresis
    Mäkinen, J
    Viljanen, MK
    Mertsola, J
    Arvilommi, H
    He, QS
    [J]. EMERGING INFECTIOUS DISEASES, 2001, 7 (06) : 952 - 958
  • [19] Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children
    Mastrantonio, P
    Spigaglia, P
    van Oirschot, H
    van der Heide, HGJ
    Heuvelman, K
    Stefanelli, P
    Mooi, FR
    [J]. MICROBIOLOGY-UK, 1999, 145 : 2069 - 2075
  • [20] Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland
    Mooi, FR
    He, QS
    van Oirschot, H
    Mertsola, J
    [J]. INFECTION AND IMMUNITY, 1999, 67 (06) : 3133 - 3134